NCT03463759 is a clinical trial in Recurrent Low Back Pain, sponsored by Aalborg University.

Who is sponsoring NCT03463759?

NCT03463759 is sponsored by Aalborg University.

What condition does NCT03463759 study?

NCT03463759 studies Recurrent Low Back Pain, Healthy.

Is NCT03463759 still recruiting?

NCT03463759 is currently completed. Last updated 11 December 2020.

Last reviewed 2020-12-11 · How we verify

NCT03463759

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pain Inhibition and Facilitation in Recurrent Low Back Pain

Completed Last updated 11 December 2020

What this trial tests

trial in Recurrent Low Back Pain in 60 participants. Completed in 14 December 2019.

Timeline

10 April 2018

Primary endpoint
14 December 2018

14 December 2019

Quick facts

Lead sponsor	Aalborg University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	10 April 2018
Primary completion	14 December 2018
Estimated completion	14 December 2019
Sites	1 location across Denmark

Conditions studied

Recurrent Low Back Pain — all drugs for Recurrent Low Back Pain →
Healthy — all drugs for Healthy →

Sponsor

Aalborg University

Who can join

Adults 18 to 60, any sex, with Recurrent Low Back Pain or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates psychophysical measures of pain inhibition and facilitation, along with cortical responses to different sensory stimuli, in patients with recurrent low back pain and matched healthy individuals.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Recurrent Low Back Pain

Currently open trials in the same condition.

NCT06452030 — Changing Trunk Muscle Activation in Patients With Recurrent Low Back Pain in Remission · NA · recruiting
NCT03737461 — Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc · Phase 2, PHASE3 · active not recruiting

Other Aalborg University trials

Trials by the same sponsor.

NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
NCT07395882 — A New Model to Induce Itch and Inflammation · NA · not yet recruiting
NCT07395869 — Off-set Analgesia Induced by Cold Temperature · NA · not yet recruiting
NCT07266103 — Mechanistic Study of Personalized rTMS in Chronic Pain · NA · not yet recruiting
NCT07373392 — Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals Wi · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03463759 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aalborg University
Last refreshed: 11 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03463759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing